These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27779300)

  • 41. [Vagus nerve stimulation in drug-resistant epilepsy. Experience with 23 patients].
    Zwoliński P; Roszkowski M; Drabik K; Baczuk L; Majkowski J
    Neurol Neurochir Pol; 2004; 38(3):161-9; discussion 170-1. PubMed ID: 15354227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes of VNS therapy with AspireSR
    Hamilton P; Soryal I; Dhahri P; Wimalachandra W; Leat A; Hughes D; Toghill N; Hodson J; Sawlani V; Hayton T; Samarasekera S; Bagary M; McCorry D; Chelvarajah R
    Seizure; 2018 May; 58():120-126. PubMed ID: 29702409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center.
    Spanaki MV; Allen LS; Mueller WM; Morris GL
    Seizure; 2004 Dec; 13(8):587-90. PubMed ID: 15519919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vagal nerve stimulation in children with drug-resistant epilepsy].
    Bremer A; Eriksson AS; Røste GK; Knudtzen B; Nakken KO
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):896-8. PubMed ID: 16554878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.
    Siddiqui F; Herial NA; Ali II
    Epilepsy Behav; 2010 Jul; 18(3):299-302. PubMed ID: 20580901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children.
    Benifla M; Rutka JT; Logan W; Donner EJ
    Childs Nerv Syst; 2006 Aug; 22(8):1018-26. PubMed ID: 16816981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vagus nerve stimulation for drug-resistant epilepsy in children and young adults.
    Buoni S; Mariottini A; Pieri S; Zalaffi A; Farnetani MA; Strambi M; Palma L; Fois A
    Brain Dev; 2004 Apr; 26(3):158-63. PubMed ID: 15030903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corpus callosotomy for childhood-onset drug-resistant epilepsy unresponsive to vagus nerve stimulation.
    Arya R; Greiner HM; Horn PS; Turner M; Holland KD; Mangano FT
    Pediatr Neurol; 2014 Dec; 51(6):800-5. PubMed ID: 25456300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vagus nerve stimulation therapy for epilepsy].
    Kawai K
    Brain Nerve; 2011 Apr; 63(4):331-46. PubMed ID: 21441636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vagal nerve stimulation: a case report.
    Higgins D; Dix D; Gold ME
    AANA J; 2010 Apr; 78(2):146-50. PubMed ID: 20583461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery.
    Vale FL; Ahmadian A; Youssef AS; Tatum WO; Benbadis SR
    Seizure; 2011 Apr; 20(3):244-8. PubMed ID: 21196125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful outcome of episodes of status epilepticus after vagus nerve stimulation: a multicenter study.
    Sierra-Marcos A; Maestro I; Rodríguez-Osorio X; Miró J; Donaire A; Aparicio J; Rumiá J; Forcadas M; Garamendi I; Pardo J; López J; Prieto Á; Plans G; Falip M; Carreño M
    Eur J Neurol; 2012 Sep; 19(9):1219-23. PubMed ID: 22891774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laryngopharyngeal dysfunction from the implant vagal nerve stimulator.
    Zalvan C; Sulica L; Wolf S; Cohen J; Gonzalez-Yanes O; Blitzer A
    Laryngoscope; 2003 Feb; 113(2):221-5. PubMed ID: 12567072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognosis of refractory epilepsy patients rejected from epilepsy surgery.
    Gonen OM; Gandelman-Marton R; Kipervasser S; Neufeld MY
    Acta Neurol Scand; 2015 Jan; 131(1):58-62. PubMed ID: 25273688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of pharmacoresistant epilepsy: stimulated refractoriness].
    Rossetti AO; Vulliémoz S
    Rev Med Suisse; 2012 May; 8(339):930, 932-4. PubMed ID: 22675822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.
    Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T
    Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life after vagal nerve stimulator insertion.
    Mikati MA; Ataya NF; El-Ferezli JC; Baghdadi TS; Turkmani AH; Comair YG; Kansagra S; Najjar MW
    Epileptic Disord; 2009 Mar; 11(1):67-74. PubMed ID: 19286494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vagus nerve stimulation for the management of seizures in children: an 8-year experience.
    Coykendall DS; Gauderer MW; Blouin RR; Morales A
    J Pediatr Surg; 2010 Jul; 45(7):1479-83. PubMed ID: 20638528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation.
    Rong P; Liu A; Zhang J; Wang Y; Yang A; Li L; Ben H; Li L; Liu R; He W; Liu H; Huang F; Li X; Wu P; Zhu B
    Chin Med J (Engl); 2014; 127(2):300-4. PubMed ID: 24438620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran.
    Pakdaman H; Amini Harandi A; Abbasi M; Karimi M; Arami MA; Mosavi SA; Haddadian K; Rezaei O; Sadeghi S; Sharifi G; Gharagozli K; Bahrami P; Ashrafi F; Kasmae HD; Ghassemi A; Arabahmadi M; Behnam B
    Neurol Sci; 2016 Nov; 37(11):1773-1778. PubMed ID: 27401807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.